Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space.

Meerwein CM, Pizzuto DA, Vital D, Morand GB, Stolzmann P, Huber GF, Huellner MW.

Head Neck. 2019 Feb;41(2):503-510. doi: 10.1002/hed.25431. Epub 2018 Dec 18.

PMID:
30561113
2.

Comparing diagnostic accuracy of 18F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infections.

Husmann L, Huellner MW, Ledergerber B, Anagnostopoulos A, Stolzmann P, Sah BR, Burger IA, Rancic Z, Hasse B; and the Vasgra Cohort.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1359-1368. doi: 10.1007/s00259-018-4205-y. Epub 2018 Nov 13.

PMID:
30426151
3.

Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: clinical implications for the assessment of lung tumors.

Messerli M, Stolzmann P, Egger-Sigg M, Trinckauf J, D'Aguanno S, Burger IA, von Schulthess GK, Kaufmann PA, Huellner MW.

EJNMMI Phys. 2018 Sep 26;5(1):27. doi: 10.1186/s40658-018-0223-x.

4.

Value of PET/MRI for assessing tumor resectability in NSCLC-intra-individual comparison with PET/CT.

Messerli M, de Galiza Barbosa F, Marcon M, Muehlematter UJ, Stolzmann P, Warschkow R, Delso G, Ter Voert EE, Huellner MW, Frauenfelder T, Veit-Haibach P.

Br J Radiol. 2018 Oct 11:20180379. doi: 10.1259/bjr.20180379. [Epub ahead of print]

PMID:
30209954
5.

Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.

Tallón de Lara P, Cecconi V, Hiltbrunner S, Yagita H, Friess M, Bode B, Opitz I, Vrugt B, Weder W, Stolzmann P, Felley-Bosco E, Stahel RA, Tischler V, Britschgi C, Soldini D, van den Broek M, Curioni-Fontecedro A.

Clin Cancer Res. 2018 Dec 15;24(24):6345-6354. doi: 10.1158/1078-0432.CCR-18-1231. Epub 2018 Aug 28.

PMID:
30154226
6.

Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients.

Meerwein CM, Nakadate M, Stolzmann P, Vital D, Morand GB, Zweifel DF, Huber GF, Huellner MW.

Clin Otolaryngol. 2018 Dec;43(6):1594-1599. doi: 10.1111/coa.13185. Epub 2018 Jul 31. No abstract available.

PMID:
29974995
7.

The role of FDG PET/CT in therapy control of aortic graft infection.

Husmann L, Ledergerber B, Anagnostopoulos A, Stolzmann P, Sah BR, Burger IA, Pop R, Weber A, Mayer D, Rancic Z, Hasse B; VASGRA Cohort Study.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1987-1997. doi: 10.1007/s00259-018-4069-1. Epub 2018 Jun 11.

PMID:
29948106
8.

Value of 18F-FET PET in adult brainstem glioma.

Albatly AA, Alsamarah AT, Alhawas A, Veit-Haibach P, Buck A, Stolzmann P, Burger IA, Kollias SS, Huellner MW.

Clin Imaging. 2018 Sep - Oct;51:68-75. doi: 10.1016/j.clinimag.2018.01.015. Epub 2018 Feb 8.

PMID:
29448122
9.

Pulmonary nodule detection in oncological patients - Value of respiratory-triggered, periodically rotated overlapping parallel T2-weighted imaging evaluated with PET/CT-MR.

de Galiza Barbosa F, Geismar JH, Delso G, Messerli M, Huellner M, Stolzmann P, Veit-Haibach P.

Eur J Radiol. 2018 Jan;98:165-170. doi: 10.1016/j.ejrad.2017.11.010. Epub 2017 Nov 16.

PMID:
29279157
10.

Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy.

Kranzbühler B, Nagel H, Becker AS, Müller J, Huellner M, Stolzmann P, Muehlematter U, Guckenberger M, Kaufmann PA, Eberli D, Burger IA.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):20-30. doi: 10.1007/s00259-017-3850-x. Epub 2017 Oct 14.

PMID:
29032394
11.

Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.

Sekine T, Barbosa FG, Delso G, Burger IA, Stolzmann P, Ter Voert EE, Huber GF, Kollias SS, von Schulthess GK, Veit-Haibach P, Huellner MW.

Head Neck. 2017 Aug;39(8):1550-1558. doi: 10.1002/hed.24783. Epub 2017 May 13.

PMID:
28500749
12.

A patient with a history of breast cancer and multiple bone lesions: a case report.

Schnyder MA, Stolzmann P, Huber GF, Schmid C.

J Med Case Rep. 2017 May 6;11(1):127. doi: 10.1186/s13256-017-1296-1.

13.

Iterative Image Reconstruction Improves the Accuracy of Automated Plaque Burden Assessment in Coronary CT Angiography: A Comparison With Intravascular Ultrasound.

Puchner SB, Ferencik M, Maehara A, Stolzmann P, Ma S, Do S, Kauczor HU, Mintz GS, Hoffmann U, Schlett CL.

AJR Am J Roentgenol. 2017 Apr;208(4):777-784. doi: 10.2214/AJR.16.17187. Epub 2017 Feb 8.

PMID:
28177655
14.

PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system.

Sekine T, de Galiza Barbosa F, Kuhn FP, Burger IA, Stolzmann P, Huber GF, Kollias SS, von Schulthess GK, Veit-Haibach P, Huellner MW.

Clin Imaging. 2017 Mar - Apr;42:232-239. doi: 10.1016/j.clinimag.2017.01.003. Epub 2017 Jan 17.

PMID:
28129606
15.

PET/MR Outperforms PET/CT in Suspected Occult Tumors.

Sekine T, Barbosa FG, Sah BR, Mader CE, Delso G, Burger IA, Stolzmann P, Ter Voert EE, von Schulthess GK, Veit-Haibach P, Huellner MW.

Clin Nucl Med. 2017 Feb;42(2):e88-e95. doi: 10.1097/RLU.0000000000001461.

16.

Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.

Sah BR, Stolzmann P, Delso G, Wollenweber SD, Hüllner M, Hakami YA, Queiroz MA, Barbosa FG, von Schulthess GK, Pietsch C, Veit-Haibach P.

Nucl Med Commun. 2017 Jan;38(1):57-66.

17.

18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response.

Burger IA, Casanova R, Steiger S, Husmann L, Stolzmann P, Huellner MW, Curioni A, Hillinger S, Schmidtlein CR, Soltermann A.

J Nucl Med. 2016 Jun;57(6):849-54. doi: 10.2967/jnumed.115.167684. Epub 2016 Jan 28.

18.

Metal artifact reduction in patients with dental implants using multispectral three-dimensional data acquisition for hybrid PET/MRI.

Gunzinger JM, Delso G, Boss A, Porto M, Davison H, von Schulthess GK, Huellner M, Stolzmann P, Veit-Haibach P, Burger IA.

EJNMMI Phys. 2014 Dec;1(1):102. doi: 10.1186/s40658-014-0102-z. Epub 2014 Dec 20.

19.

TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT.

Huellner MW, de Galiza Barbosa F, Husmann L, Pietsch CM, Mader CE, Burger IA, Stolzmann P, Delso G, Frauenfelder T, von Schulthess GK, Veit-Haibach P.

J Nucl Med. 2016 Jan;57(1):21-6. doi: 10.2967/jnumed.115.162040. Epub 2015 Oct 15.

20.

18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.

Samarin A, Hüllner M, Queiroz MA, Stolzmann P, Burger IA, von Schulthess G, Veit-Haibach P.

Nucl Med Commun. 2015 Dec;36(12):1165-73. doi: 10.1097/MNM.0000000000000387.

Supplemental Content

Loading ...
Support Center